Alumis
ALMS
Alumis (ALMS) news
Recent news
Alumis - to submit NDA to FDA for EnvueDucitinib in Q4 2026
AInvest Wire · Aug 10, 2026ImportantBiopharma Firm Alumis Shares Fall 20% After Downsized IPO
AInvest Wire · Jun 28, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
